$259.93
-1.66-0.63%
Last update: Oct 1, 4:30 PM
$260.46
-1.13-0.43%
AbbVie Inc
ABBVNYSE
AbbVie (ABBV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AbbVie (ABBV) last issued guidance on September 3, 2026 for Q3 2026. The company guided earnings per share in the range of $3.84 - $3.88, compared to a consensus EPS estimate of $3.85.
Compared to prior guidance, AbbVie maintained its EPS outlook from a previous range of $3.84 - $3.88.
AbbVie has issued 67 guidance updates between October 5, 2022 and September 3, 2026. During this period, the company raised its outlook 11 times and lowered it 35 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $3.77 | $2.66 | $2.66 | $1.78 |
| Actual | $3.65 | $2.65 | $2.71 | $1.86 |
| Surprise | -3.18% | -0.38% | +1.88% | +4.49% |
| Revenue | ||||
| Estimate | $16.76B | $14.73B | $16.39B | $15.59B |
| Actual | $16.99B | $15.00B | $16.62B | $15.78B |
| Surprise | +1.37% | +1.84% | +1.37% | +1.21% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $3.85 | $3.89 | $3.36 | $4.07 |
| Revenue | ||||
| Consensus | $17.32B | $18.31B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 31, 2026 | $3.65 | $3.77 | -3.18 % |
| Q1 | Apr 29, 2026 | $2.65 | $2.66 | -0.38 % |
| Q4 | Feb 4, 2026 | $2.71 | $2.66 | 1.88 % |
| Q3 | Oct 31, 2025 | $1.86 | $1.78 | 4.49 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 31, 2026 | $16.99B | $16.76B | 1.37 % |
| Q1 | Apr 29, 2026 | $15.00B | $14.73B | 1.84 % |
| Q4 | Feb 4, 2026 | $16.62B | $16.39B | 1.37 % |
| Q3 | Oct 31, 2025 | $15.78B | $15.59B | 1.21 % |
